Neurobiology of Aging
Volume 27, Issue 10 , Pages 1359-1371 , October 2006

Gene expression correlates of neurofibrillary tangles in Alzheimer's disease

  • Travis Dunckley

      Affiliations

    • Neurogenomics Division, Translational Genomics Research Institute, 445 North 5th Street, Phoenix, AZ 85004, USA
    • ,
  • Thomas G. Beach

      Affiliations

    • Sun Health Research Institute, USA
    • Arizona Alzheimer's Disease Research Center, USA
    • ,
  • Keri E. Ramsey

      Affiliations

    • Neurogenomics Division, Translational Genomics Research Institute, 445 North 5th Street, Phoenix, AZ 85004, USA
    • ,
  • Andrew Grover

      Affiliations

    • Sun Health Research Institute, USA
    • ,
  • Diego Mastroeni

      Affiliations

    • Sun Health Research Institute, USA
    • ,
  • Douglas G. Walker

      Affiliations

    • Sun Health Research Institute, USA
    • ,
  • Bonnie J. LaFleur

      Affiliations

    • Department of Biostatistics, Vanderbilt University, USA
    • ,
  • Keith D. Coon

      Affiliations

    • Neurogenomics Division, Translational Genomics Research Institute, 445 North 5th Street, Phoenix, AZ 85004, USA
    • ,
  • Kevin M. Brown

      Affiliations

    • Neurogenomics Division, Translational Genomics Research Institute, 445 North 5th Street, Phoenix, AZ 85004, USA
    • ,
  • Richard Caselli

      Affiliations

    • Department of Neurology, Mayo Clinic Scottsdale, USA
    • Arizona Alzheimer's Disease Research Center, USA
    • ,
  • Walter Kukull

      Affiliations

    • National Alzheimer's Coordinating Center, USA
    • ,
  • Roger Higdon

      Affiliations

    • National Alzheimer's Coordinating Center, USA
    • ,
  • Daniel McKeel

      Affiliations

    • Washington University Alzheimer's Disease Research Center, USA
    • ,
  • John C. Morris

      Affiliations

    • Washington University Alzheimer's Disease Research Center, USA
    • ,
  • Christine Hulette

      Affiliations

    • Duke University Alzheimer's Disease Research Center, USA
    • ,
  • Donald Schmechel

      Affiliations

    • Duke University Alzheimer's Disease Research Center, USA
    • ,
  • Eric M. Reiman

      Affiliations

    • Neurogenomics Division, Translational Genomics Research Institute, 445 North 5th Street, Phoenix, AZ 85004, USA
    • Banner Good Samaritan Medical Center, USA
    • Arizona Alzheimer's Disease Research Center, USA
    • ,
  • Joseph Rogers

      Affiliations

    • Sun Health Research Institute, USA
    • Arizona Alzheimer's Disease Research Center, USA
    • ,
  • Dietrich A. Stephan

      Affiliations

    • Neurogenomics Division, Translational Genomics Research Institute, 445 North 5th Street, Phoenix, AZ 85004, USA
    • Arizona Alzheimer's Disease Research Center, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 602 343 8727; fax: +1 602 343 8448.

Received 16 May 2005 ,Revised 26 July 2005 ,Accepted 8 August 2005.

References 

  1. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE, et al. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene. 2003;22:2121–2134
  2. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).. J Neurosci. 1996;16:7910–7919
  3. Baum L, Masliah E, Iimoto DS, Hansen LA, Halliday WC, Saitoh T. Casein kinase II is associated with neurofibrillary tangles but is not an intrinsic component of paired helical filaments. Brain Res. 1992;573:126–132
  4. Caceres A, Kosik KS. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature. 1990;343:461–463
  5. Caceres A, Potrebic S, Kosik KS. The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons. J Neurosci. 1991;11:1515–1523
  6. Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J. Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech. 2000;50:305–315
  7. Cau J, Faure S, Comps M, Delsert C, Morin N. A novel p21-activated kinase binds the actin and microtubule networks and induces microtubule stabilization. J Cell Biol. 2001;155:1029–1042
  8. Dan C, Nath N, Liberto M, Minden A. PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol Cell Biol. 2002;22:567–577
  9. Debure L, Vayssiere JL, Rincheval V, Loison F, Le Drean Y, Michel D. Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration. J Cell Sci. 2003;116:3109–3121
  10. DeMattos RB, O’Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2002;99:10843–10848
  11. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol. 1998;143:777–794
  12. Fisher RA. The design of experiments. 9th ed.. New York: Hafner Press; 1974;
  13. Gorath M, Stahnke T, Mronga T, Goldbaum O, Richter-Landsberg C. Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia. 2001;36:89–101
  14. Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med. 2001;7:355–362
  15. Hulette CM, Welsh-Bohmer KA, Crain B, Szymanski MH, Sinclaire NO, Roses AD. Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's disease research center experience. Arch Pathol Lab Med. 1997;121:615–618
  16. Iqbal K, Grundke-Iqbal I. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies. Curr Drug Targets. 2004;5:495–502
  17. Kempster S, Collins ME, Aronow BJ, Simmons M, Green RB, Edington N. Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice. Neuroreport. 2004;15:1735–1738
  18. Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci. 2002;22:698–707
  19. Knops J, Kosik KS, Lee G, Pardee JD, Cohen-Gould L, McConlogue L. Overexpression of tau in a nonneuronal cell induces long cellular processes. J Cell Biol. 1991;114:725–733
  20. Li Y, Liu L, Barger SW, Griffin WS. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci. 2003;23:1605–1611
  21. Lorenzl S, Albers DS, Chirichigno JW, Augood SJ, Beal MF. Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy. J Neurol Sci. 2004;218:39–45
  22. Lorenzl S, Albers DS, LeWitt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME, et al. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci. 2003;207:71–76
  23. Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, et al. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int. 2003;43:191–196
  24. Manly BF. Randomization and Monte Carlo methods in biology. New York: Chapman and Hall; 1991;
  25. Masliah E, Iimoto DS, Mallory M, Albright T, Hansen L, Saitoh T. Casein kinase II alteration precedes tau accumulation in tangle formation. Am J Pathol. 1992;140:263–268
  26. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, et al. Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet. 2004;36:969–977
  27. Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron. 2004;43:321–332
  28. Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Acta Neuropathol (Berl). 2002;104:225–230
  29. Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S. Intracellular clusterin induces G2–M phase arrest and cell death in PC-3 prostate cancer cells1. Cancer Res. 2004;64:6174–6182
  30. Smith MR, Kung H, Durum SK, Colburn NH, Sun Y. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine. 1997;9:770–780
  31. Tanji K, Mori F, Imaizumi T, Yoshida H, Satoh K, Wakabayashi K. Interleukin-1 induces tau phosphorylation and morphological changes in cultured human astrocytes. Neuroreport. 2003;14:413–417
  32. Wallace JA, Alexander S, Estrada EY, Hines C, Cunningham LA, Rosenberg GA. Tissue inhibitor of metalloproteinase-3 is associated with neuronal death in reperfusion injury. J Cereb Blood Flow Metab. 2002;22:1303–1310

PII: S0197-4580(05)00222-8

doi: 10.1016/j.neurobiolaging.2005.08.013

Neurobiology of Aging
Volume 27, Issue 10 , Pages 1359-1371 , October 2006

Article Tools

* Image Usage & Resolution